Skip to main content
SpringerLink
Log in

The treatment of cancer patients with human lymphoblastoid interferon

A comparison of two routes of administration

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Highly purified human lymphoblastoid interferon (HLBI) derived from virus-stimulated Namalwa cells was administered by 6-h IV infusion or IM injection to 40 patients with a variety of disseminated malignancies refractory to standard therapy. Each patient received doses escalating from 0.1 to 50×106 U for up to 5 weeks. Extensive monitoring for clinical effect, toxicity, and pharmacokinetics has revealed higher peak serum interferon levels and somewhat more pronounced systemic toxicity for the IV than for the IM route of administration. Objective evidence of tumor regression was observed in two patients receiving HLBI IV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahstrom L, Dohlwitz A, Strander H, Carlstrom G, Cantell K (1977) Interferon in acute leukemia in children. Lancet 1:166

    Google Scholar 

  2. Billiau A (1981) Interferon therapy: Pharmacokinetic and pharmacological aspects. Arch Virol 67:121

    Google Scholar 

  3. Bose S, Hickman J (1977) Role of carbohydrate moiety in determining the survival of interferon in the circulation. J Biol Chem 252:8336

    Google Scholar 

  4. Cantell K, Pyhälä L (1976) Pharmacokinetics of human leukocyte interferon. J Infect Dis 133:46

    Google Scholar 

  5. Finter NB, Fantes KH (1980) The purity and safety of interferons prepared for clinical use: The case for lymphoblastoid interferon. In: Gresser I (ed) Interferon. Academic Press, New York, p 65

    Google Scholar 

  6. Greenberg PL, Mosny SA (1977) Cytotoxic effects of interferon in vitro on granulocytic progenitor cells. Cancer Res 37:1794

    Google Scholar 

  7. Gresser I, Tovey MG (1978) Antitumor effects of interferon. Biochim Biophys Acta 516:231

    Google Scholar 

  8. Gutterman JU, Blumenschein GR, Alexanian R, Yap H-Y, Buzdar AV, Gabanillas F, Hortobagyi G, Hersh E, Rasmussen SL, Harmon M, Kramer M, Pestka S (1980) Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 93:399

    Google Scholar 

  9. Hill NO, Loeb E, Pardue AS, Dorn GL, Khan A, Hill JM (1979) Response of acute leukemia to leukocyte interferon. J Clin Hematol Oncol 9:137

    Google Scholar 

  10. Huang A, Laszlo J, Brenckman W (1982) Lymphoblastoid interferon (Wellferon) trial in chronic lymphocytic leukemia in progressive phase. Proc Am Assoc Clin Res 27:113

    Google Scholar 

  11. Krim M (1980) Towards tumor therapy with interferons. Blood 55:875

    Google Scholar 

  12. McNeil TA, Gresser I (1973) Inhibition of haemopoietic colony growth by interferon preparations from different sources. Nature New Biol 244:173

    Google Scholar 

  13. Mellstedt H, Ahre A, Bjorkholm M, Holm G, Johansson B, Strander H (1979) Interferon therapy in myelomatosis. Lancet 1:245

    Google Scholar 

  14. Merigan TC, Sikora K, Breeden JH, Levy R, Rosenberg SA (1978) Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. N Engl J Med 229:1449

    Google Scholar 

  15. Nissen C, Speck B, Emodi G, Iscove NW (1977) Toxicity of human interferon preparations for human bone marrow cultures. Lancet 2:203

    Google Scholar 

  16. Priestman TJ (1979) Interferon: An anti-cancer agent? Cancer Treat Rev 6:223

    Google Scholar 

  17. Priestman TJ (1980) Initial evaluation of lymphoblastoid interferon in patients with advanced malignant disease. Lancet 2:113

    Google Scholar 

  18. Retsas S, Priestman TJ, Newton KA, Westbury G (1981) Evaluation of human lymphoblastoid interferon (HLBI) in metastatic malignant melanoma: A phase II study. Proc Am Soc Clin Oncol 22:371

    Google Scholar 

  19. Rohatiner AZS, Balkwill F, Malpas JS, Lister TA (1981) A phase I study of intravenous human lymphoblastoid interferon in patients with haematological malignancies. In: Modern trends in human leukemia, vol IV. Springer, New York, p 63

    Google Scholar 

  20. Rohatiner AZS, Balkwill F, Griffin, DB, Malpas JS, Lister TA (1982) A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion. Cancer Chemother Pharmacol 9:97

    Google Scholar 

  21. Sarna G, Figlin R, Bryson Y, Mauritzon N, Cline M (1982) A phase I trial of human lymphoblastoid interferon (Huly InF) administered intermittently. Proc Am Soc Clin Oncol 18:39

    Google Scholar 

  22. Sherwin SA, Knost JA, Fein S, Abrams PG, Foon KA, Ochs J, Schoenberger C, Maluish AE, Oldham RK (1982) A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA 248:2461

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute Frederick Cancer Research Facility, 21701, Frederick, MD

    James A. Knost, Stephen A. Sherwin, Paul G. Abrams, Jeffrey J. Ochs, Kenneth A. Foon, Roxanne Williams & Robert K. Oldham

  2. Burroughs-Wellcome Co., Research Triangle Park, 27709, NC, USA

    Richard Tuttle

Authors
  1. James A. Knost
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen A. Sherwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul G. Abrams
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey J. Ochs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenneth A. Foon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roxanne Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Richard Tuttle
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert K. Oldham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knost, J.A., Sherwin, S.A., Abrams, P.G. et al. The treatment of cancer patients with human lymphoblastoid interferon. Cancer Immunol Immunother 15, 144–148 (1983). https://doi.org/10.1007/BF00199706

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199706

Keywords

Search

Navigation